Leaflet SERDOLECT 4mg film-coated tablets


Indicated for: schizophrenia; bipolar disorder

Route of administration: oral

Substance: sertindole (antipsychotic)

ATC: N05AE03 (Nervous system | Antipsychotics | Indole derivatives)

Sertindole is an atypical antipsychotic used for the treatment of schizophrenia. It works by blocking dopamine and serotonin receptors in the brain, reducing psychotic symptoms such as hallucinations and delusions.

The medication is taken orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor cardiac function.

Patients should be aware of potential side effects, such as dizziness, weight gain, or QT interval prolongation. It is important to inform the doctor of any unusual symptoms.

Common side effects include dizziness, weight gain, and dry mouth. In rare cases, severe reactions such as cardiac arrhythmias or neuroleptic malignant syndrome may occur. Patients should be informed of these risks before starting treatment.

General data about SERDOLECT 4mg

  • Substance: sertindole
  • Date of last drug list: 01-05-2026
  • Commercial code: W44017001
  • Concentration: 4mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 30
  • Product type: original
  • Price: 119.44 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: H. LUNDBECK A/S - DANEMARCA
  • Holder: H. LUNDBECK A/S - DANEMARCA
  • Number: 7720/2015/01
  • Shelf life: 5 years

Concentrations available for sertindole

  • 12mg
  • 16mg
  • 20mg
  • 4mg

Compensation lists for SERDOLECT 4mg Lundbeck

G15 (C1) - Mental disorders

Price

Copayment

Patient

119.44 RON

119.44 RON

0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price

Copayment

Patient

119.44 RON

119.44 RON

0.00 RON